The implication of single-nucleotide polymorphisms in ovarian hyperstimulation syndrome
Sayyed Mohammad Hossein Ghaderian
Urogenital Stem Cell Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Sayyed Mohammad Hossein Ghaderian and Reza Akbarzadeh are contributed equally to this work.
Search for more papers by this authorReza Akbarzadeh
Urogenital Stem Cell Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Institute of Anatomy, University of Lübeck, Lübeck, Germany
Sayyed Mohammad Hossein Ghaderian and Reza Akbarzadeh are contributed equally to this work.
Search for more papers by this authorFatemeh Mohajerani
Department of Genetics, Tehran Medical Sciences Branch, Islamic Azad University, Tehran, Iran
Search for more papers by this authorZohreh Khodaii
Dietary Supplements and Probiotics Research Center, Alborz University of Medical Sciences, Karaj, Iran
Search for more papers by this authorCorresponding Author
Saghar Salehpour
Preventative Gynecology Research Center (PGRC), Shahid Beheshti University of Medical Sciences, Tehran, Iran
Correspondence Saghar Salehpour, MD, Preventative Gynecology Research Center (PGRC), Shahid Beheshti University of Medical Sciences, Tehran, Iran. Email: [email protected]
Search for more papers by this authorSayyed Mohammad Hossein Ghaderian
Urogenital Stem Cell Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Sayyed Mohammad Hossein Ghaderian and Reza Akbarzadeh are contributed equally to this work.
Search for more papers by this authorReza Akbarzadeh
Urogenital Stem Cell Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Institute of Anatomy, University of Lübeck, Lübeck, Germany
Sayyed Mohammad Hossein Ghaderian and Reza Akbarzadeh are contributed equally to this work.
Search for more papers by this authorFatemeh Mohajerani
Department of Genetics, Tehran Medical Sciences Branch, Islamic Azad University, Tehran, Iran
Search for more papers by this authorZohreh Khodaii
Dietary Supplements and Probiotics Research Center, Alborz University of Medical Sciences, Karaj, Iran
Search for more papers by this authorCorresponding Author
Saghar Salehpour
Preventative Gynecology Research Center (PGRC), Shahid Beheshti University of Medical Sciences, Tehran, Iran
Correspondence Saghar Salehpour, MD, Preventative Gynecology Research Center (PGRC), Shahid Beheshti University of Medical Sciences, Tehran, Iran. Email: [email protected]
Search for more papers by this authorAddress: Imam Hossein Hospital, Shahid Madani Street, 1617763141 Tehran, Iran
Abstract
Ovarian hyperstimulation syndrome (OHSS) is an undesirable complication in the course of ovarian stimulation. This kind of stimulation is aimed at acquiring a sufficient number of high-quality oocytes in in vitro fertilization (IVF). Whereas the predisposition to OHSS could be impacted by genetic polymorphisms in susceptible genes, the present study has been jointly conducted with an Iranian cohort to scrutinize its relevant implication. Genomic DNA was extracted from blood samples of patients with a normal ovarian response (NOR) or with OHSS. Samples were analyzed to detect polymorphisms MTHFR rs1801131, MTHFR rs1801133, AMHR2 rs2002555, LHCGR rs2293275, PGR rs10895068, and SERPINE1 rs1799889. Variations of MTHFR, AMHR2, LHCGR, and PGR genes were significantly associated with the developing OHSS. After correction for multiple analysis, this difference was not evident for PGR genotypes. The polymorphic alleles of MTHFR (rs1801131 C-allele and rs1801133 T-allele), AMHR2 (rs2002555 G-allele), and LHCGR (rs2293275 G-allele) were significantly more prevalent among patients with OHSS compared to those in the NOR group. In contrast, the minor allele of PGR single-nucleotide polymorphism (SNP) (rs10895068, A-allele) was more prominent among patients with a NOR than those with OHSS. No significant difference was observed in genotypes or alleles of SERPINE1 rs1799889. The observations indicated that the minor alleles of MTHFR, AMHR2, and LHCGR genes could be considered an independent risk factor in susceptibility to OHSS. Nevertheless, polymorphic allele in the PGR rs10895068 SNP contributes to preventing OHSS occurrence. Therefore, it can be argued that these genes have a significant impact on OHSS.
CONFLICT OF INTERESTS
The authors declare that there are no conflict of interests.
REFERENCES
- Akison, L., & Robker, R. (2012). The critical roles of progesterone receptor (PGR) in ovulation, oocyte developmental competence and oviductal transport in mammalian reproduction. Reproduction in Domestic Animals, 47(Suppl 4), 288–296.
- Altmäe, S., Hovatta, O., Stavreus-Evers, A., & Salumets, A. (2011). Genetic predictors of controlled ovarian hyperstimulation: Where do we stand today? Human Reproduction Update, 17(6), 813–828.
- Anderson, C. A., Pettersson, F. H., Clarke, G. M., Cardon, L. R., Morris, A. P., & Zondervan, K. T. (2010). Data quality control in genetic case-control association studies. Nature Protocols, 5(9), 1564–1573.
- Azem, F., Many, A., Ben Ami, I., Yovel, I., Amit, A., Lessing, J. B., … Kupferminc, M. J. (2004). Increased rates of thrombophilia in women with repeated IVF failures. Human Reproduction, 19(2), 368–370.
- Barad, D. H., Weghofer, A., & Gleicher, N. (2009). Comparing anti-Müllerian hormone (AMH) and follicle-stimulating hormone (FSH) as predictors of ovarian function. Fertility and Sterility, 91(4 Suppl), 1553–1555.
- Boudjenah, R., Molina-Gomes, D., Torre, A., Bergere, M., Bailly, M., Boitrelle, F., … Vialard, F. (2012). Genetic polymorphisms influence the ovarian response to rFSH stimulation in patients undergoing in vitro fertilization programs with ICSI. PLoS One, 7(6), e38700.
- Chan, W. S. (2009). The ‘ART' of thrombosis: A review of arterial and venous thrombosis in assisted reproductive technology. Current Opinion in Obstetrics and Gynecology, 21(3), 207–218.
- Chaudhary, S., Panda, A. K., Mishra, D. R., & Mishra, S. K. (2013). Association of +331G/A PgR polymorphism with susceptibility to female reproductive cancer: Evidence from a meta-analysis. PLoS One, 8(1), e53308.
- Cramer, D. W., Hornstein, M. D., McShane, P., Powers, R. D., Lescault, P. J., Vitonis, A. F., … De Vivo, I. (2003). Human progesterone receptor polymorphisms and implantation failure during in vitro fertilization. American Journal of Obstetrics and Gynecology, 189(4), 1085–1092.
- Demirel, E., Turhan, U., Ekmekci, E., Subasioglu, A., & Kelekci, S. (2016). Severe spontaneous ovarian hyperstimulation syndrome with cervical insufficiency: A case report. Journal of Fertilization, 4(2), 181.
- Dulitzky, M., Cohen, S. B., Inbal, A., Seidman, D. S., Soriano, D., Lidor, A., … Rabinovici, J. (2002). Increased prevalence of thrombophilia among women with severe ovarian hyperstimulation syndrome. Fertility and Sterility, 77(3), 463–467.
- Eriksson, P., Nilsson, L., Karpe, F., & Hamsten, A. (1998). Very-low-density lipoprotein response element in the promoter region of the human plasminogen activator inhibitor-1 gene implicated in the impaired fibrinolysis of hypertriglyceridemia. Arteriosclerosis, Thrombosis, and Vascular Biology, 18(1), 20–26.
- Ferrara, F., Meli, F., Amato, C., Cospite, V., Raimondi, F., & Novo, S. (2005). A case of ovarian hyperstimulation syndrome associated with the methylenetetrahydrofolate reductase mutation gene. Fertility and Sterility, 84(1), 218.
- Hanevik, H. I., Hilmarsen, H. T., Skjelbred, C. F., Tanbo, T., & Kahn, J. A. (2010). Single nucleotide polymorphisms in the anti-Mullerian hormone signalling pathway do not determine high or low response to ovarian stimulation. Reproductive BioMedicine Online, 21(5), 616–623.
- Hiraoka, M., & Kagawa, Y. (2017). Genetic polymorphisms and folate status. Congenital Anomalies (Kyoto), 57(5), 142–149.
- Humaidan, P., Nelson, S. M., Devroey, P., Coddington, C. C., Schwartz, L. B., Gordon, K., … Stegmann, B. J. (2016). Ovarian hyperstimulation syndrome: Review and new classification criteria for reporting in clinical trials. Human Reproduction, 31(9), 1997–2004.
- Ingraham, H. A., Hirokawa, Y., Roberts, L. M., Mellon, S. H., McGee, E., Nachtigal, M. W., … Visser, J. A. (2000). Autocrine and paracrine Mullerian inhibiting substance hormone signaling in reproduction. Recent Progress in Hormone Research, 55, 53–67.
- Kerkela, E., Skottman, H., Friden, B., Bjuresten, K., Kere, J., & Hovatta, O. (2007). Exclusion of coding-region mutations in luteinizing hormone and follicle-stimulating hormone receptor genes as the cause of ovarian hyperstimulation syndrome. Fertility and Sterility, 87(3), 603–606.
- Kevenaar, M. E., Themmen, A. P., Laven, J. S., Sonntag, B., Fong, S. L., Uitterlinden, A. G., … Visser, J. A. (2007). Anti-Mullerian hormone and anti-Mullerian hormone type II receptor polymorphisms are associated with follicular phase estradiol levels in normo-ovulatory women. Human Reproduction, 22(6), 1547–1554.
- Lazaros, L., Fotaki, A., Pamporaki, C., Hatzi, E., Kitsou, C., Zikopoulos, A., … Georgiou, I. (2016). The ovarian response to standard gonadotropin stimulation is influenced by AMHRII genotypes. Gynecological Endocrinology, 32(8), 641–645.
- Lemes, R. B., Nunes, K., Carnavalli, J. E. P., Kimura, L., Mingroni-Netto, R. C., Meyer, D., … Otto, P. A. (2018). Inbreeding estimates in human populations: Applying new approaches to an admixed Brazilian isolate. PLOS One, 13(4), e0196360.
- Lindgren, I., Baath, M., Uvebrant, K., Dejmek, A., Kjaer, L., Henic, E., … Giwercman, Y. L. (2016). Combined assessment of polymorphisms in the LHCGR and FSHR genes predict chance of pregnancy after in vitro fertilization. Human Reproduction, 31(3), 672–683.
- Lupski, J. R., Belmont, J. W., Boerwinkle, E., & Gibbs, R. A. (2011). Clan genomics and the complex architecture of human disease. Cell, 147(1), 32–43.
- Machac, S., Lubusky, M., Prochazka, M., & Streda, R. (2006). Prevalence of inherited thrombophilia in patients with severe ovarian hyperstimulation syndrome. Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia, 150(2), 289–292.
- Manau, D., Balasch, J., Arroyo, V., Jimenez, W., Fabregues, F., Casamitjana, R., … Vanrell, J. A. (1998). Circulatory dysfunction in asymptomatic in vitro fertilization patients. Relationship with hyperestrogenemia and activity of endogenous vasodilators. The Journal of Clinical Endocrinology and Metabolism, 83(5), 1489–1493.
- La Marca, A., Sighinolfi, G., Radi, D., Argento, C., Baraldi, E., Artenisio, A. C., … Volpe, A. (2010). Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Human Reproduction Update, 16(2), 113–130.
- Mayorga, M. P., Gromoll, J., Behre, H. M., Gassner, C., Nieschlag, E., & Simoni, M. (2000). Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype. Journal of Clinical Endocrinology and Metabolism, 85(9), 3365–3369.
- Moran, C. (2006). Nonclassic adrenal hyperplasia. Fertility and Sterility, 86(Suppl 1), S3.
- Orvieto, R. (2005). Can we eliminate severe ovarian hyperstimulation syndrome? Human Reproduction, 20(2), 320–322.
- Pabalan, N., Montagna, E., Singian, E., Tabangay, L., Jarjanazi, H., Barbosa, C. P., … Bianco, B. (2016). Associations of polymorphisms in anti-müllerian hormone (AMH Ile49Ser) and its type II receptor (AMHRII −482 A>G) on reproductive outcomes and polycystic ovary syndrome: A systematic review and meta-analysis. Cellular Physiology and Biochemistry, 39(6), 2249–2261.
- Peluso, C., Fonseca, F. L., Gastaldo, G. G., Christofolini, D. M., Cordts, E. B., Barbosa, C. P., … Bianco, B. (2015). AMH and AMHR2 polymorphisms and AMH serum level can predict assisted reproduction outcomes: A cross-sectional study. Cellular Physiology and Biochemistry, 35(4), 1401–1412.
- Pemberton, T. J., Absher, D., Feldman, M. W., Myers, R. M., Rosenberg, N. A., & Li, J. Z. (2012). Genomic patterns of homozygosity in worldwide human populations. American Journal of Human Genetics, 91(2), 275–292.
- Piersma, D., Verhoef-Post, M., Look, M. P., Uitterlinden, A. G., Pols, H. A., Berns, E. M., … Themmen, A. P. (2007). Polymorphic variations in exon 10 of the luteinizing hormone receptor: Functional consequences and associations with breast cancer. Molecular and Cellular Endocrinology, 276(1-2), 63–70.
- Rizk, B. (2009). Symposium: Update on prediction and management of OHSS. Genetics of ovarian hyperstimulation syndrome. Reproductive BioMedicine Online, 19(1), 14–27.
- Robker, R. L., Akison, L. K., & Russell, D. L. (2009). Control of oocyte release by progesterone receptor-regulated gene expression. Nuclear Receptor Signaling, 7, e012.
- Rosen, M. P., Shen, S., McCulloch, C. E., Rinaudo, P. F., Cedars, M. I., & Dobson, A. T. (2007). Methylenetetrahydrofolate reductase (MTHFR) is associated with ovarian follicular activity. Fertility and Sterility, 88(3), 632–638.
- Sanchez, F., & Smitz, J. (2012). Molecular control of oogenesis. Biochimica et Biophysica Acta, 1822(12), 1896–1912.
- Santos-Ribeiro, S., Polyzos, N. P., Stouffs, K., De Vos, M., Seneca, S., Tournaye, H., … Blockeel, C. (2015). Ovarian hyperstimulation syndrome after gonadotropin-releasing hormone agonist triggering and “freeze-all”: In-depth analysis of genetic predisposition. Journal of Assisted Reproduction and Genetics, 32(7), 1063–1068.
- Smith, V., Osianlis, T., & Vollenhoven, B. (2015). Prevention of ovarian hyperstimulation syndrome: A review. Obstetrics and Gynecology International, 2015, 514159.
- Soares, S. R., Troncoso, C., Bosch, E., Serra, V., Simon, C., Remohi, J., … Pellicer, A. (2005). Age and uterine receptiveness: Predicting the outcome of oocyte donation cycles. Journal of Clinical Endocrinology and Metabolism, 90(7), 4399–4404.
- Sticchi, E., Romagnuolo, I., Cellai, A. P., Lami, D., Fedi, S., Prisco, D., … Fatini, C. (2012). Fibrinolysis alterations in infertile women during controlled ovarian stimulation: Influence of BMI and genetic components. Thrombosis Research, 130(6), 919–924.
- Tamura, T., & Picciano, M. F. (2006). Folate and human reproduction. American Journal of Clinical Nutrition, 83(5), 993–1016.
- Thaler, C. J. (2014). Folate Metabolism and Human Reproduction. Geburtshilfe und Frauenheilkunde, 74(9), 845–851.
- Thaler, C. J., Budiman, H., Ruebsamen, H., Nagel, D., & Lohse, P. (2006). Effects of the common 677C>T mutation of the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene on ovarian responsiveness to recombinant follicle-stimulating hormone. American Journal of Reproductive Immunology, 55(4), 251–258.
- Thathapudi, S., Kodati, V., Erukkambattu, J., Addepally, U., & Qurratulain, H. (2015). Association of luteinizing hormone chorionic gonadotropin receptor gene polymorphism (rs2293275) with polycystic ovarian syndrome. Genetic Testing and Molecular Biomarkers, 19(3), 128–132.
- Ueland, P. M., Hustad, S., Schneede, J., Refsum, H., & Vollset, S. E. (2001). Biological and clinical implications of the MTHFR C677T polymorphism. Trends In Pharmacological Sciences, 22(4), 195–201.
- Wu, C. H., Chen, Y. C., Wu, H. H., Yang, J. G., Chang, Y. J., & Tsai, H. D. (2009). Serum anti-Mullerian hormone predicts ovarian response and cycle outcome in IVF patients. Journal of Assisted Reproduction and Genetics, 26(7), 383–389.
- Ye, Y., Vattai, A., Zhang, X., Zhu, J., Thaler, C. J., Mahner, S., … von Schönfeldt, V. (2017). Role of plasminogen activator inhibitor type 1 in pathologies of female reproductive diseases. International Journal of Molecular Sciences, 18(8). pii: E1651.
- Zetterberg, H., Regland, B., Palmer, M., Ricksten, A., Palmqvist, L., Rymo, L., … Blennow, K. (2002). Increased frequency of combined methylenetetrahydrofolate reductase C677T and A1298C mutated alleles in spontaneously aborted embryos. European Journal of Human Genetics, 10(2), 113–118.